A5H-28723-96623
3 vaccinations
2 coded responses
16 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 761 / TX
- Registered
- 2021-03-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-02
Dose 1 — Pfizer-BioNTech
-
2021-03-26
Registered in v-safe
-
2021-03-26
Dose 2 — Pfizer-BioNTech
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-05-01
- 2021-06-25
- 2021-09-24
-
2021-12-07
Dose 3 — Pfizer-BioNTech
-
2022-03-28
Survey response — 12 months, dose 2MedDRA: Sinusitis — Feeling: GoodFree text: Sinus infection. On day 7 of 10 to 14 days of expected symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-12-07
Survey response — 12 months, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: 8 months pregnantMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-02 | Pfizer-BioNTech | |
| 2 | 2021-03-26 | Pfizer-BioNTech | |
| 3 | 2021-12-07 | Pfizer-BioNTech | No |
Free text
Release 11 — 12 months, dose 2
Symptoms: Sinus infection. On day 7 of 10 to 14 days of expected symptoms
Release 12 — 12 months, dose 3
Symptoms: 8 months pregnant
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release